Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?

Daniel J. Landsburg, Brad S. Kahl

Research output: Contribution to journal › Editorial

Fingerprint

Dive into the research topics of 'Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?'. Together they form a unique fingerprint.